Sean Pokorney is a Cardiology physician affiliated with Duke Medical Center. OpenAlex indexes 246 publications with 3,980 citations (h-index 33); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2209 S Sterling St Ste 530
Morganton, NC 286554093
Telephone
828-580-4230Registry record last updated 30 Nov 2017.
Clinical trials
- CIED Infection Quality Initiative Demonstration Project
Sponsor: Duke University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year2025104 payments$62,532openpaymentsdata.cms.gov ↗
- Philips North America LLCProgram year202525 payments$29,656openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202536 payments$17,679openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.2%Beta blocker20.4%Metoprolol Succinate71%Sotalol12%Metoprolol Tartrate9%Carvedilol8%Part D<11 patientsAntiarrhythmic18.7%Amiodarone Hcl54%Flecainide Acetate18%Multaq8%Dofetilide7%Mexiletine Hcl7%Propafenone Hcl Er6%Part D<11 patients+ 7 more classes in this area
Blood & clotting
25.2%Factor Xa inhibitor25.2%Eliquis78%Xarelto22%Part D≥70 patientsMetabolism & gastrointestinal
7.6%SGLT2 inhibitor6.1%Jardiance100%Part D≥20 patientsGLP-1 receptor agonist1.5%Wegovy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early Lead Extraction for Infected Implanted Cardiac Electronic Devices
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Scott Cousins, MD
Duke Medical Center
James Abbruzzese, MD
Duke Medical Center
Priya Kishnani
Duke Medical Center
David Durack, MD
Duke Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”